NA Sperm Separation Devices Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 52
1.1 OBJECTIVES OF THE STUDY 52
1.2 MARKET DEFINITION 52
1.3 OVERVIEW OF THE NORTH AMERICA SPERM SEPARATION DEVICES MARKET 52
1.4 LIMITATIONS 54
1.5 MARKETS COVERED 54
2 MARKET SEGMENTATION 57
2.1 MARKETS COVERED 57
2.2 GEOGRAPHICAL SCOPE 58
2.3 YEARS CONSIDERED FOR THE STUDY 59
2.4 CURRENCY AND PRICING 59
2.5 DBMR TRIPOD DATA VALIDATION MODEL 60
2.6 MULTIVARIATE MODELLING 63
2.7 END USER LIFELINE CURVE 63
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 64
2.9 DBMR MARKET POSITION GRID 65
2.10 MARKET APPLICATION COVERAGE GRID 67
2.11 VENDOR SHARE ANALYSIS 68
2.12 SECONDARY SOURCES 69
2.13 ASSUMPTIONS 69
3 EXECUTIVE SUMMARY 70
4 PREMIUM INSIGHTS 73
4.1 PORTERS FIVE FORCES 75
4.2 PESTEL ANALYSIS 76
5 INDUSTRIAL INSIGHTS 77
6 NORTH AMERICA SPERM SEPARATION DEVICES MARKET: REGULATIONS 78
6.1 REGULATION IN THE U.S. 78
6.1.1 GUIDELINES FOR MANUFACTURER 78
6.2 REGULATION IN EUROPE 79
6.2.1 GUIDELINES FOR MANUFACTURERS 79
6.3 REGULATION IN CANADA 79
6.3.1 GUIDELINES FOR MANUFACTURERS 79
6.4 REGULATION IN SOUTH AFRICA 80
6.4.1 GUIDELINES FOR MANUFACTURERS 80
7 MARKET OVERVIEW 81
7.1 DRIVERS 83
7.1.1 INCREASE IN INCIDENCE OF INFERTILITY IN MEN AND WOMEN 83
7.1.2 RISE IN THE IVF, INTRAUTERINE INSEMINATION (IUI), AND INTRA-CERVICAL INSEMINATION (ICI) 83
7.1.3 INCREASE IN HEALTHCARE EXPENDITURE 84
7.1.4 STRATEGIC INITIATIVES TAKEN BY VARIOUS MARKET PLAYERS 85
7.2 RESTRAINTS 85
7.2.1 HIGH COST OF SPERM SEPARATION DEVICES 85
7.2.2 STRICT REGULATORY 86
7.3 OPPORTUNITIES: 86
7.3.1 RISE IN NUMBER OF RESEARCH AND DEVELOPMENT ACTIVITIES 86
7.3.2 INCREASING PUBLIC AWARENESS ABOUT THE FERTILITY 87
7.4 CHALLENGES 88
7.4.1 COMPLICATIONS AND SIDE EFFECTS ASSOCIATED WITH PROCEDURES AND DEVICES 88
7.4.2 SHORTAGE OF SKILLED PERSONNEL 88
8 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY DEVICES 89
8.1 OVERVIEW 90
8.2 CENTRIFUGATION-FREE DEVICES 93
8.2.1 BY TYPE 93
8.2.1.1 MIGRATION-SEDIMENTATION (MS) 94
8.2.1.2 MICROFLUIDIC SPERM SORTERS (MFSS) 94
8.2.2 BY DESIGN TYPE 94
8.2.2.1 STANDARD 94
8.2.2.2 OBLIQUE 94
8.2.2.3 COIL 94
8.2.3 BY VOLUME 95
8.2.3.1 LESS THAN 1ML 95
8.2.3.2 1-3 ML 95
8.2.3.3 MORE THAN 3 ML 95
8.2.4 BY TECHNOLOGY 95
8.2.4.1 MICROFLUIDIC 96
8.2.4.2 PHOTONIC 96
8.2.4.3 OTHERS 96

8.3 CENTRIFUGATION DEVICES 96
8.3.1 BY TYPE 97
8.3.1.1 DENSITY GRADIENT (DG) SEPARATION 97
8.3.1.2 SWIM UP (SU) 97
8.3.2 BY DESIGN TYPE 97
8.3.2.1 STANDARD 97
8.3.2.2 OBLIQUE 97
8.3.2.3 COIL 98
8.3.3 BY VOLUME 98
8.3.3.1 LESS THAN 1ML 98
8.3.3.2 1-3 ML 98
8.3.3.3 MORE THAN 3 ML 98
8.3.4 BY TECHNOLOGY 98
8.3.4.1 MICROFLUIDIC 99
8.3.4.2 PHOTONIC 99
8.3.4.3 OTHERS 99
9 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY MEDIA 100
9.1 OVERVIEW 101
9.2 SPERM FREEZING MEDIA 104
9.3 SPERM PROCESSING MEDIA 104
9.4 SPERM WASHING MEDIA 105
9.5 OTHER MEDIA 106
10 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY ASSISTED DEVICES 107
10.1 OVERVIEW 108
10.2 IMAGING SYSTEMS 111
10.3 INCUBATOR 111
10.4 CABINET 112
10.5 OTHERS 113
11 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY TECHNOLOGY 114
11.1 OVERVIEW 115
11.2 ELECTROPHORESIS 118
11.3 DIELECTROPHORESIS 118
11.4 ON-CHIP 119

12 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY APPLICATION 120
12.1 OVERVIEW 121
12.2 FERTILITY 124
12.2.1 IN-VITRO FERTILIZATION 125
12.2.2 INTRAUTERINE INSEMINATION 125
12.2.3 INTRA-CERVICAL INSEMINATION 125
12.3 FORENSICS 125
12.4 DIAGNOSTICS 126
12.5 OTHERS 127
13 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY DISTRIBUTION CHANNEL 128
13.1 OVERVIEW 129
13.2 DIRECT TENDER 132
13.3 THIRD PARTY DISTRIBUTORS 132
13.4 OTHERS 133
14 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY END USER 134
14.1 OVERVIEW 135
14.2 IVF LABORATORIES 138
14.3 HOSPITALS 138
14.4 FERTILITY CENTERS 139
14.5 CLINICS 140
14.6 RESEARCH INSTITUTES 140
14.7 CRYOBANKS 141
14.8 SURGICAL CENTERS 142
14.9 OTHERS 143
15 NORTH AMERICA SPERM SEPARATION DEVICES MARKET, BY GEOGRAPHY 144
15.1 NORTH AMERICA 145
15.1.1 U.S. 157
15.1.2 CANADA 163
15.1.3 MEXICO 169
16 NORTH AMERICA SPERM SEPARATION DEVICES MARKET: COMPANY LANDSCAPE 175
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 175

17 COMPANY PROFILE 176
17.1 THE COOPER COMPANIES INC. 176
17.1.1 COMPANY SNAPSHOT 176
17.1.2 REVENUE ANALYSIS 176
17.1.3 COMPANY SHARE ANALYSIS 177
17.1.4 PRODUCT PORTFOLIO 177
17.1.5 RECENT DEVELOPMENTS 177
17.2 BONRAYBIO CO., LTD 179
17.2.1 COMPANY SNAPSHOT 179
17.2.2 COMPANY SHARE ANALYSIS 179
17.2.3 PRODUCT PORTFOLIO 180
17.2.4 RECENT DEVELOPMENT 180
17.3 MENICON CO., LTD. 181
17.3.1 COMPANY SNAPSHOT 181
17.3.2 REVENUE ANALYSIS 181
17.3.3 COMPANY SHARE ANALYSIS 182
17.3.4 PRODUCT PORTFOLIO 182
17.3.5 RECENT DEVELOPMENTS 182
17.4 MEMPHASYS 183
17.4.1 COMPANY SNAPSHOT 183
17.4.2 REVENUE ANALYSIS 183
17.4.3 COMPANY SHARE ANALYSIS 184
17.4.4 PRODUCT PORTFOLIO 184
17.4.5 RECENT DEVELOPMENTS 184
17.5 SAR HEALTHLINE PVT LTD 185
17.5.1 COMPANY SNAPSHOT 185
17.5.2 COMPANY SHARE ANALYSIS 185
17.5.3 PRODUCT PORTFOLIO 186
17.5.4 RECENT DEVELOPMENT 186
17.6 DXNOW 187
17.6.1 COMPANY SNAPSHOT 187
17.6.2 PRODUCT PORTFOLIO 187
17.6.3 RECENT DEVELOPMENT 187
17.7 GYNOTEC 188
17.7.1 COMPANY SNAPSHOT 188
17.7.2 PRODUCT PORTFOLIO 188
17.7.3 RECENT DEVELOPMENT 188

17.8 HAMILTON THORNE, LTD. 189
17.8.1 COMPANY SNAPSHOT 189
17.8.2 REVENUE ANALYSIS 189
17.8.3 PRODUCT PORTFOLIO 190
17.8.4 RECENT DEVELOPMENTS 190
17.9 KOEK BIOTECHNOLOGY BIOENGINEERING AND MEDICAL SERVICES INDUSTRY & TRADE INC. 191
17.9.1 COMPANY SNAPSHOT 191
17.9.2 PRODUCT PORTFOLIO 191
17.9.3 RECENT DEVELOPMENT 191
17.10 NIDACON INTERNATIONAL AB 192
17.10.1 COMPANY SNAPSHOT 192
17.10.2 PRODUCT PORTFOLIO 192
17.10.3 RECENT DEVELOPMENT 192
17.11 PROMEGA CORPORATION 193
17.11.1 COMPANY SNAPSHOT 193
17.11.2 PRODUCT PORTFOLIO 193
17.11.3 RECENT DEVELOPMENT 193
17.12 SEAFORIA 194
17.12.1 COMPANY SNAPSHOT 194
17.12.2 PRODUCT PORTFOLIO 194
17.12.3 RECENT DEVELOPMENT 194
17.13 SPERM PROCESSOR PVT LTD. 195
17.13.1 COMPANY SNAPSHOT 195
17.13.2 PRODUCT PORTFOLIO 195
17.13.3 RECENT DEVELOPMENT 195
18 QUESTIONNAIRE 196
19 RELATED REPORTS 199